Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data

Main Article Content

Jonette Keri
Leon Kircik
Lawrence Green
Glynis Ablon
William Werschler
Emil Tanghetti
Zoe Draelos
Eric Guenin

Keywords

acne

Abstract

N/A

References

1. Heng AHS, Chew FT. Sci Rep. 2020;10(1):5754.

2. Dreno B. JEADV. 2017;31(5):8-12.

3. K Yang L, Colditz GA. JAMA Intern Med. 2015;175(8):1412-3.

4. Kolotkin RL, Meter K, Williams GR. Obes Rev. 2001;2(4):219-229.

5. Gieler U, Gieler T, Kupfer JP. J Eur Acad Dermatol Venereol. 2015;29 Suppl 4:12-14.

6. Tanghetti EA, Werschler WP, Lain E, et al. J Drugs Dermatol. 2020;19(3):272-279.

7. Kircik LH, Lain E, Gold M, et al. J Drugs Dermatol. 2020;19(11):1086-1092.

8. Skroza N, Tolino E, Proietti I, et al. G Ital Dermatol Venereol. 2016;151(1):87-92

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>